Influence of patient care provider on patient health outcomes in allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 95, Issue 2, 2005, Pages 167-174

  Szeinbach, Sheryl L ^a   Williams, P Brock ^b   Kucukarslan, Suzan ^c   Elhefni, Hanaa ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY;

ALLERGIC RHINITIS; ARTICLE; CHI SQUARE DISTRIBUTION; DIAGNOSTIC TEST; FAMILY HISTORY; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MANAGEMENT; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATIENT CARE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; RETROSPECTIVE STUDY; SERODIAGNOSIS; SKIN TEST;

EID: 23844500352     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61207-0     Document Type: Article

References (51)

1. Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99:22-27.
2. Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998;81(pt 2):478-518.
3. National Institute for Health Care Management. Prescription Drug Expenditures in 2000: The Upward Trend Continues. Washington, DC: National Institute for Health Care Management; 2001.
4. Nathan RA, Meltzer EO, Selner JC, Storms W. Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99:S808-S814.
5. Sly R. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Immunol. 1999;82:233-252.
6. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc. 1994;15:21-25.
7. Williams PB, Ahlstedt S, Barnes JH, Soderstrom L, Portnoy J. Are our impressions of allergy test performance correct? Ann Allergy Asthma Immunol. 2003;91:26-33.
8. Ricci G, Capelli M, Miniero R, et al. A comparison of different allergometric tests, skin prick test, Pharmacia UniCAP® and ADVIA Centaur®, for diagnosis of allergic diseases in children. Allergy. 2003;58:38-45.
9. Seiner JC, Sullivan TJ, Ahlstedt S, et al. Current issues relating to in vitro testing for allergen-specific IgE: a workshop report. Ann Allergy Asthma Immunol. 1999;82:407-412.
10. Emanuel IA. In vitro testing for allergy diagnosis: comparison of methods in common use. Otolaryngol Clin North Am. 1998; 31:27-33.
11. Patorello EA, Icorvaia C, Ortolani C, et al. Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy, 1: definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens. J Allergy Clin Immunol. 1995; 96:580-587.
12. Williams PB, Barnes JH, Szeinbach SL, Sullivan TJ. Analytic precision and accuracy of commercial immunoassay for specific IgE: establishing a standard. J Allergy Clin Immunol. 2000;105: 1221-1230.
13. Soderstrom L, Kober A, Ahlstedt S, et al. A further evaluation of the clinical use of specific IgE antibody testing in allergic disease. Allergy. 2003;58:921-928.
14. Szeinbach SL, Barnes JH, Sullivan TJ, Williams PB. Precision and accuracy of commercial laboratories' ability to classify positive and/or negative allergen-specific IgE results. Ann Allergy Asthma Immunol. 2001;86:1-9.
15. Cuffel B, Wamboldt M, Borish L, Kennedy S, Crystal-Peters J. Economic consequences of comorbid depression, anxiety, and allergic rhinitis. Psychosomatics. 1999;40:491-496.
16. Bell IR, Jasnoski ML, Kagan J, King DS. Depression and allergies: survey of a nonclinical population. Psychother Psychosom. 1991;55:24-31.
17. Scadding GK, Richards DH, Price MJ. Patient and physician perspectives on the impact and management of perennial and seasonal allergic rhinitis. Clin Otolaryngol. 2000;25:551-557.
18. Blanc PD, Trupin L, Eisner M, et al. The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol. 2001;54:610-618.
19. Juniper EF. Quality of life in allergic rhinitis. Ann Allergy Asthma Immunol. 1999;83:449-454.
20. Juniper EF. Quality of Life in adults and children with asthma and rhinitis. Allergy. 1997;52:971-977.
21. Meltzer EO, Nathan RA, Selnar JC, Storms W. Quality of life and rhinitis symptoms: results of a national survey with the SF-36 and RQLQ questionnaires. J Allergy Clin Immunol. 1997; 99:s815-s819.
22. DeGraafin't Veld T, Koenders S, Garrelds IM, Vanwijk RG. The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J Allergy Clin Immunol. 1996;98:508-513.
23. Ray NF, Baraniuk JN, Thamer M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. J Allergy Clin Immunol. 1999;103:401-407.
24. Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care. 2000;6:373-378.
25. IMS Health Data. March 2003. Available at: http://www. imshealth.com.
26. Berger WE, Shoheiber O, Ledgerwood GL, Cannon E, Giaquinta DB. New challenges to old standards in the treatment of rhinitis. J Manag Care Pharm. 2001;7:S2-S13.
27. Meltzer EO, Casale TB, Nathan RA, Thompson AK. Once-daily Fexofenadine HCL improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1999;83:311-317.
28. Reily MC, Tanner LA, Meltzer EO. Allergy impairment questionnaires: validation studies. J Allergy Clin Immunol. 1996;97:989.
29. Ware JE, Kosinski M, Dewey JE, Gandek B. How to Score and Interpret Single Item Health Status Measures: A Manual for Users of the SF-8 Health Survey. Lincoln, RI: Quality Metric Inc; 2001.
30. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353-365.
31. Stevens JP. K group MANOVA: a priori and post hoc procedures. In: Applied Multivariate Statistics for the Social Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates Inc; 1992: 226.
32. Overton TS, Armstrong JS. Estimating non-response in mail surveys. J Market Res. 1977;14:396-402.
33. Sokal RR, Rohlf FJ. Single classification analysis of variance. In: Biometry. 2nd ed. San Francisco, CA: WH Freeman & Co; 1981:245.
34. Greenberg P, Birnbaum HG, Kessler RC, Morgan M, Stang P. Impact of illness and its treatment on workplace costs: regulatory and measurement issues. J Occup Environ Med. 2001;43: 56-63.
35. Ross RN. The costs of allergic rhinitis. Am J Manag Care. 1996;2:285-290.
36. Luce MF, Kahn BE. Avoidance or vigilance? the psychology of false-positive test results. J Consumer Res. 1999;26:242-259.
37. Wardle J, Pope R. The psychological costs of screening for cancer. J Psychosom Res. 1992;36:609-624.
38. Rogan W. Gladen B. Estimating prevalence from the results of a screening test. Am J Epidemiol. 1978;107:71-76.
39. Luce MF. Choosing to avoid: coping with negatively emotion-laden consumer decision. J Consumer Res. 1998;24:409-433.
40. Williams PB, Siegel C, Portnoy J. Efficacy of a single diagnostic test for sensitization to common inhalant allergens. Ann Allergy Asthma Immunol. 2001;86:196-202.
41. Szeinbach SL, Williams PB, Muntendam P, O'Connor RD. Identification of allergic disease among users of antihistamines. J Manag Care Pharm. 2004;10:234-238.
42. Wood RA, Phipatanakul W, Hamilton RG, Eggleston PA. A comparison of skin prick test, intradermal skin tests, and RASTs in the diagnosis of cat allergy. J Allergy Clin Immunol. 1999; 103:773-779.
43. Nelson HS, Oppenheimer J, Buchmeier A, Kordash TR, Freshwater LL. An assessment of the role of intradermal skin testing in the diagnosis of clinical relevant allergy to timothy grass. J Allergy Clin Immunol. 1996;97:1193-1201.
44. Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med. 2004; 140:278-289.
45. American Academy of Allergy, Asthma, and Immunology. The Allergy Report. Milwaukee, WI: American Academy of Allergy, Asthma, and Immunology; 2001.
46. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality-of-life in patients with perennial allergic rhinitis with the French version of the SF-36 health-status questionnaire. J Allergy Clin Immunol. 1994;94: 182-188.
47. Ciprani G, Ricca V, Tosca M, Landi M, Passalacqua G, Cononica GW. Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy. Allergy. 1999;54:358-365.
48. Rajagopalan R, Anderson RT, Sarma S, Retchin C, Jones J. The use of decision-analytical modeling in economic evaluation of patch testing in allergic contact dermatitis. Pharmacoecomics. 1998;14:79-95.
49. Pai Chih-Wen, Ozcan YA, Jiang HJ. Regional variation in physician practice pattern: an examination of technical and cost efficiency for treating sinusitis. J Med Syst. 2000;24:103-117.
50. Majani G, Bairardini I, Giardini A, et al. Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy. 2001;56:313-317.
51. Campbell DT, Stanley JC. Experimental and Quasi-experimental Designs for Research. Chicago, IL: Rand McNally; 1963.